中文版 
Spain 
Arabic
Russian
Korean
Thai
vietnamese
Persian
Deutsch
Türkce
日本語
Mechanism of Action: Retatrutide is a triple receptor agonist that targets the receptors of GIP, GLP-1, and glucagon hormones. By combining the effects of native GIP and GLP-1 with glucagon receptor activation, it exerts a broad appetite-suppressing and metabolic impact. Researchers suggest that this triple mechanism may offer more effective glycemic control and weight loss compared to other incretin-based therapies. Notable Studies: · Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist a step forward in the treatment of diabetes and obesity? · Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA - The Lancet · Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial | New England Journal of Medicine What is Retatrutide? Retatrutide, a synthetic peptide created by Eli Lilly, is also known by its development code LY3437943. This peptide acts as a triple receptor agonist, targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulino ...
Read More
Mechanism of Action: Retatrutide is a triple receptor agonist that targets the receptors of GIP, GLP-1, and glucagon hormones. By combining the effects of native GIP and GLP-1 with glucagon receptor activation, it exerts a broad appetite-suppressing and metabolic impact. Researchers suggest that this triple mechanism may offer more effective glycemic control and weight loss compared to other incretin-based therapies. Notable Studies: · Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist a step forward in the treatment of diabetes and obesity? · Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA - The Lancet · Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial | New England Journal of Medicine What is Retatrutide? Retatrutide, a synthetic peptide created by Eli Lilly, is also known by its development code LY3437943. This peptide acts as a triple receptor agonist, targeting the glucagon-like peptide-1 (GLP-1), glucose-depe ...
Read More
Mechanism of Action: Retatrutide is a triple receptor agonist that targets the receptors of GIP, GLP-1, and glucagon hormones. By combining the effects of native GIP and GLP-1 with glucagon receptor activation, it exerts a broad appetite-suppressing and metabolic impact. Researchers suggest that this triple mechanism may offer more effective glycemic control and weight loss compared to other incretin-based therapies. Notable Studies: · Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist a step forward in the treatment of diabetes and obesity? · Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA - The Lancet · Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial | New England Journal of Medicine What is Retatrutide? Retatrutide, a synthetic peptide created by Eli Lilly, is also known by its development code LY3437943. This peptide acts as a triple receptor agonist, targeting the glucagon-like peptide-1 (GLP-1), glucose-depe ...
Read More
Mechanism of Action: Retatrutide is a triple receptor agonist that targets the receptors of GIP, GLP-1, and glucagon hormones. By combining the effects of native GIP and GLP-1 with glucagon receptor activation, it exerts a broad appetite-suppressing and metabolic impact. Researchers suggest that this triple mechanism may offer more effective glycemic control and weight loss compared to other incretin-based therapies. Notable Studies: · Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist a step forward in the treatment of diabetes and obesity? · Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA - The Lancet · Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial | New England Journal of Medicine What is Retatrutide? Retatrutide, a synthetic peptide created by Eli Lilly, is also known by its development code LY3437943. This peptide acts as a triple receptor agonist, targeting the glucagon-like peptide-1 (GLP-1), glucose-depe ...
Read More
Description PT-141, also known as bremelanotide, is an innovative new peptide hormone therapy for men and women that improves sexual function. PT-141 is an effective and highly effective treatment for erectile dysfunction and increased libido in men, and for improving sexual arousal disorders in women. PT 141 peptide gives you desire and drive while increasing blood flow to the penis or vagina and clitoris, restoring intimacy and passion to your relationship. PT 141 addresses these issues and helps resolve sexual difficulties. PT-141 works directly through the nervous system to increase arousal, desire, and sexual satisfaction. Drugs such as Viagra and Cialis work through the vascular system and only give you an erection. However, PT-141 not only gives you an erection, it also gives you desire and drive, restoring intimacy and passion to your relationship. Benefits of PT 141 PT 141 works by stimulating melanocortin receptors in the brain. It can be injected subcutaneously or inhaled through the nose to treat sexual dysfunction. It is known to work quickly, usually in less than an hour. This peptide can offer many benefits to men and women with decreased libido and sexual performance. Treati ...
Read More
What is PEG-MGF peptide? PEG MGF, short for PEGylated mechano-growth factor, is a two-component anabolic peptide. PEG MGF is a well-known derivative of the compound insulin-like growth factor-1 (IGF-1). IGF-1 is thought to play an important role in the regulation of growth hormone (GH). In addition, this chemical may also help promote bone and tissue growth. PEG MGF promotes muscle growth by prompting various receptors to drive myoblasts to divide. Several studies have also shown that PEG MGF can increase the number of muscle stem cells that bind to existing muscle cells, thereby promoting muscle growth. PEG MGF has a short half-life of about 5 to 7 minutes. To address this, this experimental chemical is PEGylated. PEGylation is performed by adding polyethylene glycol (PEG) to the peptide. By adding the PEG group, the half-life of MGF can be safely and effectively extended to 48-72 hours. Possible Applications of PEGylated Mechano-Growth Factor Peptides: PEG MGF Peptides and Bone Repair In the animal model mouse, MGF treatment improved the migration of chondrocytes (cells responsible for cartilage formation) from the bone to the cartilage where they are needed. PEGylated Mec ...
Read More
PE-22-28 Research PE-22-28 is a synthetic derivative of the naturally occurring peptide Spadin, which binds to TREK-1, a protein found in areas of the brain that control mood, memory, and learning. It is being investigated for its potential benefits in treating depression, improving memory and learning, aiding stroke recovery, and potentially combating neurodegenerative diseases such as Alzheimer’s. PE-22-28 and Treatment of Depression PE-22-28 has shown promising results in the treatment of depression. The peptide specifically blocks the TREK-1 channel, a mechanism that has been linked to antidepressant activity. In comparison to spadin, PE-22-28 has demonstrated better specificity and affinity for the TREK-1 channel, with an IC50 (half maximal inhibitory concentration) of 0.12 nM versus 40-60 nM for spadin. In behavioral models of depression, such as the forced swimming test, mice treated with PE-22-28 showed a significant reduction in immobility time, indicating an antidepressant effect. Furthermore, PE-22-28 was found to have improved in vivo stability and bioavailability compared to spadin, maintaining its activity for up to 23 hours instead of 7 hours. PE-22-28 Stimulates Neuro ...
Read More
what is P21 P21 is a modified synthetic CNTF analog. CNTF is a natural protein mediator of neuronal growth in humans. The effects of CNTF have been studied primarily in the nervous system, although there are receptors for the peptide in other parts of the body, such as bones. Studies have shown that it can promote the synthesis of neurotransmitters and the growth of neurites. It can also protect neurons and their supporting cells from inflammatory attacks. In addition to its neurotrophic effects, CNTF can increase satiety, thereby reducing food intake. CNTF and cerebrolysin are not the same molecule. P21 is also not the same as cerebrolysin. It is discussed below and compared to P21. Recombinant CNTF was developed under the brand name Axokine. It is being tested for the treatment of amyotrophic lateral sclerosis and is not currently available for sale. Interestingly, the body quickly develops antibodies to Axokine, suggesting that it may be possible to use P21 and exogenous CNTF together in some cases to increase CNTF levels while keeping antibody activity to a minimum . What does P21 do? In simple terms, P21 can enhance cognition and protect the central nervous system from damage. It app ...
Read More
What is oxytocin? The peptide hormone is made up of 9 amino acids. It is produced in the hypothalamus, an area of the brain that controls heart rate, blood pressure, and digestion. OT is released into the bloodstream by the posterior pituitary gland. Oxytocin was discovered by Sir Henry Dale in 1996. He found that extracts from the posterior pituitary gland of humans caused the uterus of pregnant cats to contract. Sir Henry Dale also coined the name oxytocin, which means "quick labor" in Greek. This peptide hormone controls many functions. It has an impact on labor, milk secretion during breastfeeding, and bonding with newborns in humans. It also plays an important role in sexual arousal, romantic attachment, and other social interactions. It is also known as the "love hormone." A 2012 study found that levels of this hormone were significantly higher in newly-in-love people than in singles. The findings suggest that it may play an important role in the initial stages of a relationship. Pure Rawz sells this product for research use only. How does oxytocin work? Research suggests that it interacts with neural pathways responsible for processing motivation-related stimuli. In particular, it ...
Read More
NAD+ Research A large number of animal and human studies have been conducted on the potential applications of NAD+. Here are some relevant findings: NAD+ Anti-Aging Many people are looking for anti-aging secrets, and a study found that nicotinamide adenine dinucleotide (NAD+) levels decline with age, which may cause cell damage and may shorten lifespan. NAD+ acts as an enzyme cofactor and substrate for a variety of regulatory proteins in many important biological pathways. A large number of studies have shown that increasing NAD+ levels in tissues or cells can slow the aging process. The safety and efficacy of NAD+ have been clinically studied. There is evidence that supplementing NAD+ precursors or inhibiting NAD+ degradation may enhance metabolic activity. Studies have shown that supplementing NAD+ precursors can slow the aging process in mice. To date, the anti-aging properties of NAD+ have not been confirmed in humans. The role of NAD+ in neurodegenerative diseases Several articles mentioned that NAD+ depletion has been observed in both normal and accelerated aging. Neurodegeneration is seen in several accelerated aging diseases, including a ...
Read More
Mechanism of Action: While the precise mechanism of action of MOTS-c is currently under investigation, it is hypothesized that its metabolic effects are mediated through its translocation to the nucleus and subsequent activation of AMPK. Notable Studies: · MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction. · The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. · MOTS-c Functionally Prevents Metabolic Disorders. Metabolites. What is MOTS-c? MOTS-c, is a mitochondrial-derived peptide, consisting of 16 residues encoded by the 12S rRNA region of the mitochondrial genome. This means that the genetic information that is translated into the peptide’s amino acid sequence has not been processed into a strip of mRNA. Rather, the peptide is translated from a strand of rRNA whose main role is not to carry genetic information but to help ribosomes work in processing such information. MOTS-cwas discovered in 2015 and has since attracted attention for its potential role in metabolic regulation and age-related conditi ...
Read More
Mechanism of Action: While the precise mechanism of action of MOTS-c is currently under investigation, it is hypothesized that its metabolic effects are mediated through its translocation to the nucleus and subsequent activation of AMPK. Notable Studies: · MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction. · The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. · MOTS-c Functionally Prevents Metabolic Disorders. Metabolites. What is MOTS-c? MOTS-c, is a mitochondrial-derived peptide, consisting of 16 residues encoded by the 12S rRNA region of the mitochondrial genome. This means that the genetic information that is translated into the peptide’s amino acid sequence has not been processed into a strip of mRNA. Rather, the peptide is translated from a strand of rRNA whose main role is not to carry genetic information but to help ribosomes work in processing such information. MOTS-cwas discovered in 2015 and has since attracted attention for its potential role in metabolic regulation and age-related conditi ...
Read More
